A Family With the Most Significant History of Breast and Ovarian Cancer in the US
source: pixabay.com

A Family With the Most Significant History of Breast and Ovarian Cancer in the US

  Susan Winn’s family history of ovarian and breast cancer can be traced back to the 1860s. Susan’s adult daughters, Kathryn, Bridget and Maureen, were recently interviewed with CURE® (Cancer Updates Research…

Continue Reading A Family With the Most Significant History of Breast and Ovarian Cancer in the US
New Approach Uses CRISPR-Cas9 to Boost Fetal Hemoglobin Production to Treat Blood Disorders
source: pixabay.com

New Approach Uses CRISPR-Cas9 to Boost Fetal Hemoglobin Production to Treat Blood Disorders

  An article published earlier this year by Fierce Biotech outlines an approach that was developed by researchers at the Fred Hutchinson Cancer Research Center. Using CRISPR-Cas9’s gene-editing method the researchers were…

Continue Reading New Approach Uses CRISPR-Cas9 to Boost Fetal Hemoglobin Production to Treat Blood Disorders
Multiple Sclerosis’s “Miraculous” Experience with Experimental Drug Trials
source: pixabay.com

Multiple Sclerosis’s “Miraculous” Experience with Experimental Drug Trials

As originally reported by the Oklahoma Medical Research Foundation; Tonja Martin was running through her retirement savings for her medical care. She spent $3,400 every month to cover treatment for…

Continue Reading Multiple Sclerosis’s “Miraculous” Experience with Experimental Drug Trials

Parents React to Novartis’ International “Baby Lottery” for Zolgensma with Hope But Also With Outrage

According to a recent article in Euronews, this year one hundred children who were diagnosed with spinal muscular atrophy (SMA) will receive Zolgensma, the world’s highest-priced drug, at no cost.…

Continue Reading Parents React to Novartis’ International “Baby Lottery” for Zolgensma with Hope But Also With Outrage
Close Menu